COTI-2
BMS-599626 Hydrochloride
SU16f
SIAIS178
Lumretuzumab
Propargyl-PEG1-acrylate
Galanthamine-O-methyl-d3
G6PDi-1
Boc-Aminooxy-PEG2-C2-amine
Flubendazole
Propargyl-PEG4-O-C1-Boc
BI-4142
GGTI298
PF-04937319(hydrate)
RC363
m-PEG9-NHS ester
N-(m-PEG4)-N'-(hydroxy-PEG2)-Cy5
exo BCN-O-PNB
SB 205607 dihydrobromide
DBCO-NH-PEG7-C2-NHS ester
HER2-IN-12
STAT3-SH2 domain inhibitor 1
N-(Azido-PEG3)-N-Fluorescein-PEG3-acid
PROTAC EGFR degrader 7
HO-PEG10-CH2COOH
VM4-037
Azetidine-2-carboxylic acid
DBCO-NHCO-PEG6-Biotin
Tetrazine-Ph-NHCO-PEG4-NH-Boc
Hydrocortisone cypionate
Pentoxyresorufin
HCAIX-IN-2
DSPE-PEG46-DBCO
PROTAC EGFR degrader 2
Isonixin
Cbz-NH-PEG3-CH2COOH
Sovaprevir
Eicosapentaenoyl Serotonin
Ioxitalamate monoethanolamine
IP7e
Methylene Blue(hydrate)
GW837016X
Bromoenol lactone
Ifenprodil(RC61-91)
Butoxycarbonyl-PEG5-sulfonic acid
Snf 9007
AG1024(Tyrphostin AG 1024)
NH-bis(m-PEG8)
SERCA2a activator 1
TTA-Q6
2,4-Pyridinedicarboxylic Acid
Olopatadine-d3(hydrochloride)
Nifetepimine
SN-23862
IPS-05002
Somatostatin(3-6)
KT109
TGR5 Receptor Agonist
Bromo-PEG1-CH2COOH
FTISADTSK acetate
